The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...

The ongoing investigation by Wyden and his Democratic compatriots from the Finance Committee has pointed the finger at ...

(Reuters) -Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's ...

President Trump has claimed in the past Pfizer sat on positive vaccine data, but no evidence has supported the accusation.

Pfizer (NYSE:PFE) shares reached a session low on Wednesday after The Wall Street Journal reported that the U.S. attorney’s ...

Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...

Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...

An exclusive interview with Pfizer’s Wayne Simmons on reshaping customer experience by listening to those interacting with ...

Pfizer reportedly offered about 618 million shares through a placement with investors, according to a Wednesday statement.

Dividend stocks have remained a popular choice among investors due to the steady income they provide, becoming even more ...

Biotech company Immunai, which developed an AI-based immune system mapping technology for drug development, announces the ...